JPM BETA US TR 3-10 YR ETF (BBIB) Stock News
NYSEARCA:BBIB - NYSE Arca - US46654Q8490 - ETF - Currency: USD
BBIB Latest News, Press Relases and Analysis
All
Press Releases
10 months ago - Benzinga
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases
Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.
2 years ago - Seeking Alpha
Biogen stock gains on FDA briefing docs on Alzheimer’s drug
The FDA commented on Biogen's (BBIB) and Eisai's (ESALF) (ESAIY), Alzheimer's therapy, Leqembi, sending the shares of the U.S. biotech higher Wednesday. Read more here.
Mentions: BIIB